Pharmacological treatment of schizophrenia with comorbid substance use disorder (vol 17, pg 231, 2016)

被引:0
|
作者
Azorin, J-M
Simon, N.
Adida, M.
Belzeaux, R.
机构
关键词
D O I
10.1517/14656566.2016.1132817
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Pharmacological treatment of schizophrenia with comorbid substance use disorder
    Azorin, Jean-Michel
    Simon, Nicolas
    Adida, Marc
    Belzeaux, Raoul
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (02) : 231 - 253
  • [2] Treatment of Schizophrenia and Comorbid Substance Use Disorder
    Green, Alan, I
    Salomon, Melinda S.
    Brenner, Mark J.
    Rawlins, Kimberly
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (02) : 129 - 139
  • [3] Pharmacological treatment of comorbid PTSD and substance use disorder: Recent progress
    Sofuoglu, Mehmet
    Rosenheck, Robert
    Petrakis, Ismene
    [J]. ADDICTIVE BEHAVIORS, 2014, 39 (02) : 428 - 433
  • [4] Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
    Lahteenvuo, M.
    Luykx, J.
    Taipale, H.
    Mittendorfer-Rutz, E.
    Tanskanen, A.
    Batalla, A.
    Tiihonen, J.
    [J]. EUROPEAN PSYCHIATRY, 2021, 64 : S161 - S161
  • [5] Schizophrenia and comorbid substance use disorder: Effects of antipsychotics
    Green, AI
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 : 21 - 26
  • [6] Treatment of patients with schizophrenia and comorbid substance use disorders
    Dilbaz, Nesrin
    Darcin, Asli Enez
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 21 (01): : 80 - 90
  • [7] Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder
    Naglich, Andrew
    Adinoff, Bryon
    Brown, E. Sherwood
    [J]. CNS DRUGS, 2017, 31 (08) : 665 - 674
  • [8] Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder
    Andrew Naglich
    Bryon Adinoff
    E. Sherwood Brown
    [J]. CNS Drugs, 2017, 31 : 665 - 674
  • [9] Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review
    Arranz, Belen
    Garriga, Marina
    Garcia-Rizo, Clemente
    San, Luis
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (02) : 227 - 242
  • [10] Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder
    Potvin, S.
    Pampoulova, T.
    Mancini-Marie, A.
    Lipp, O.
    Bouchard, R-H
    Stip, E.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (06): : 796 - 798